Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Steven Doerstling, Pär Hedberg, John Öhrvik, Jerzy Leppert & Egil Henriksen. (2018) Growth differentiation factor 15 in a community-based sample: age-dependent reference limits and prognostic impact. Upsala Journal of Medical Sciences 123:2, pages 86-93.
Read now
Read now
Magdalena Krintus, Marek Kozinski, Jacek Kubica & Grazyna Sypniewska. (2014) Critical appraisal of inflammatory markers in cardiovascular risk stratification. Critical Reviews in Clinical Laboratory Sciences 51:5, pages 263-279.
Read now
Read now
Articles from other publishers (29)
Natalia Nowak, Celine De Looze, Aisling O’Halloran, Rose Anne Kenny & Donal J Sexton. (2023) The association between kidney function, cognitive function, and structural brain abnormalities in community-dwelling individuals aged 50+ is mediated by age and biomarkers of cardiovascular disease. Cardiovascular Research 119:11, pages 2106-2116.
Crossref
Crossref
Ellen-Sofie HansenKristian Hindberg, Nadezhda LatyshevaPål Aukrust, Thor Ueland, John-Bjarne Hansen, Sigrid K. Brækkan & Vânia M. Morelli. (2020) Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism. Blood 136:16, pages 1863-1870.
Crossref
Crossref
Kamal Esalatmanesh, Hamidreza Fayyazi, Roozbeh Esalatmanesh & Alireza Khabbazi. (2020) The association between serum levels of growth differentiation factor‐15 and rheumatoid arthritis activity. International Journal of Clinical Practice 74:9.
Crossref
Crossref
Paweł T. Matusik, Barbara Małecka, Jacek Lelakowski & Anetta Undas. (2019) Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation. Clinical Research in Cardiology 109:4, pages 426-434.
Crossref
Crossref
Fien M. Verhamme, Christine M. Freeman, Guy G. Brusselle, Ken R. Bracke & Jeffrey L. Curtis. (2019) GDF-15 in Pulmonary and Critical Care Medicine. American Journal of Respiratory Cell and Molecular Biology 60:6, pages 621-628.
Crossref
Crossref
Mathijs C. Bodde, Maaike P. J. Hermans, Arnoud van der Laarse, Bart Mertens, Fred P. H. T. M. Romijn, Martin J. Schalij, Christa M. Cobbaert & J. Wouter Jukema. (2019) Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. Cardiology and Therapy 8:1, pages 29-41.
Crossref
Crossref
Liu Zhu, Chao Li, Qiang Liu, Weiting Xu & Xiang Zhou. (2019) Molecular biomarkers in cardiac hypertrophy. Journal of Cellular and Molecular Medicine 23:3, pages 1671-1677.
Crossref
Crossref
Ana Luisa Cardoso, Adelaide Fernandes, Juan Antonio Aguilar-Pimentel, Martin Hrabě de Angelis, Joana Ribeiro Guedes, Maria Alexandra Brito, Saida Ortolano, Giovambattista Pani, Sophia Athanasopoulou, Efstathios S. Gonos, Markus Schosserer, Johannes Grillari, Pärt Peterson, Bilge Guvenc Tuna, Soner Dogan, Angelika Meyer, Ronald van Os & Anne-Ulrike Trendelenburg. (2018) Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases. Ageing Research Reviews 47, pages 214-277.
Crossref
Crossref
Efstathios Kastritis, Ioannis PapassotiriouGiampaolo Merlini, Paolo Milani, Evangelos TerposMarco Basset, Athanasios AkalestosFrancesca Russo, Erasmia PsimenouFilia ApostolakouMaria RoussouMaria GavriatopoulouEvangelos Eleutherakis-PapaiakovouDespina FotiouDimitrios C. ZiogasElektra PapadopoulouConstantinos PamboucasMeletios A. Dimopoulos & Giovanni Palladini. (2018) Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis. Blood 131:14, pages 1568-1575.
Crossref
Crossref
志强 朱. (2018) Correlation between GDF-15, OPG, YKL-40 and Acute Myocardial Infarction. Advances in Clinical Medicine 08:02, pages 148-153.
Crossref
Crossref
Gang Li, Yan Li, Xiao-qiu Tan, Peng Jia, Jian Zhao, Dong Liu, Ting Wang & Bin Liu. (2017) Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease. Pediatric Cardiology 38:8, pages 1620-1626.
Crossref
Crossref
Shaoyi Wang, Mengyu Li, Wenjie Zhang, Hongfei Hua, Ningtao Wang, Jun Zhao, Jing Ge, Xinquan Jiang, Zhiyuan Zhang, Dongxia Ye & Chi Yang. (2017) Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect. Scientific Reports 7:1.
Crossref
Crossref
Arash Bidadkosh, Sebastiaan P.H. Lambooy, Hiddo J. Heerspink, Michelle J. Pena, Robert H. Henning, Hendrik Buikema & Leo E. Deelman. (2017) Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy. Diabetes Care 40:6, pages 784-792.
Crossref
Crossref
Lung-An Hsu, Semon Wu, Jyh-Ming Jimmy Juang, Fu-Tien Chiang, Ming-Sheng Teng, Jeng-Feng Lin, Hsuan-Li Huang & Yu-Lin Ko. (2017) Growth Differentiation Factor 15 May Predict Mortality of Peripheral and Coronary Artery Diseases and Correlate with Their Risk Factors. Mediators of Inflammation 2017, pages 1-13.
Crossref
Crossref
Marja K. Puurunen, Danielle Enserro, Vanessa Xanthakis, Martin G. Larson, Emelia J. Benjamin, Geoffrey H. Tofler, Kai C. Wollert, Christopher J. O'Donnell & Ramachandran S. Vasan. (2016) Biomarkers for the prediction of venous thromboembolism in the community. Thrombosis Research 145, pages 34-39.
Crossref
Crossref
Dhayana Dallmeier, Hermann Brenner, Ute Mons, Wolfgang Rottbauer, Wolfgang Koenig & Dietrich Rothenbacher. (2016) Growth Differentiation Factor 15, Its 12-Month Relative Change, and Risk of Cardiovascular Events and Total Mortality in Patients with Stable Coronary Heart Disease: 10-Year Follow-up of the KAROLA Study. Clinical Chemistry 62:7, pages 982-992.
Crossref
Crossref
Hakki Yilmaz, Muzaffer Cakmak, Tahir Darcin, Osman Inan, Mukadder Ayse Bilgic, Nuket Bavbek & Ali Akcay. (2015) Can Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients?. Indian Journal of Hematology and Blood Transfusion 32:2, pages 221-227.
Crossref
Crossref
MEI ZHANG, KUNYING PAN, QIANPING LIU, XIN ZHOU, TIEMIN JIANG & YUMING LI. (2016) Growth differentiation factor 15 may protect the myocardium from no-reflow by inhibiting the inflammatory-like response that predominantly involves neutrophil infiltration. Molecular Medicine Reports 13:1, pages 623-632.
Crossref
Crossref
Priya Londhe & Denis C. Guttridge. (2015) Inflammation induced loss of skeletal muscle. Bone 80, pages 131-142.
Crossref
Crossref
Azza Abdel Gawad Tantawy, Amira Abdel Moneam Adly, Eman Abdel Rahman Ismail, Omneya Ibrahim Youssef & Mohamed ElSayed Ali. (2015) Growth differentiation factor-15 in children and adolescents with thalassemia intermedia: Relation to subclinical atherosclerosis and pulmonary vasculopathy. Blood Cells, Molecules, and Diseases 55:2, pages 144-150.
Crossref
Crossref
H. Yilmaz, H.T. Çelik, O.M. Gurel, M.A. Bilgic, M. Namuslu, H. Bozkurt, A. Ayyildiz, O. Inan, N. Bavbek & A. Akcay. (2014) Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysisErhöhte Serum-GDF-15-Level sind assoziiert mit Mortalität und subklinische Atherosklerose bei Langzeit-Hämodialyse-Patienten. Herz 40:S3, pages 305-312.
Crossref
Crossref
Renske Altena, Rudolf S. N. Fehrmann, Hink Boer, Elisabeth G. E. de Vries, Coby Meijer & Jourik A. Gietema. (2015) Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage. PLOS ONE 10:1, pages e0115372.
Crossref
Crossref
Lars WallentinZiad HijaziUlrika AnderssonJohn H. AlexanderRaffaele De CaterinaMichael HannaJohn D. HorowitzElaine M. HylekRenato D. LopesSignild ÅsbergChristopher B. GrangerAgneta Siegbahn. (2014) Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation. Circulation 130:21, pages 1847-1858.
Crossref
Crossref
Paul Collinson. (2014) The role of cardiac biomarkers in cardiovascular disease risk assessment. Current Opinion in Cardiology 29:4, pages 366-371.
Crossref
Crossref
Xin-ye Xu, Ying Nie, Fang-fang Wang, Yan Bai, Zhi-zhen Lv, You-yi Zhang, Zi-jian Li & Wei Gao. (2014) Growth Differentiation Factor (GDF)-15 Blocks Norepinephrine-induced Myocardial Hypertrophy via a Novel Pathway Involving Inhibition of Epidermal Growth Factor Receptor Transactivation. Journal of Biological Chemistry 289:14, pages 10084-10094.
Crossref
Crossref
Peter Damman, Tibor Kempf, Fons Windhausen, Jan P. van Straalen, Anja Guba-Quint, Johan Fischer, Jan G.P. Tijssen, Kai C. Wollert, Robbert J. de Winter & Alexander Hirsch. (2014) Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: An Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy. International Journal of Cardiology 172:2, pages 356-363.
Crossref
Crossref
Lars Wallentin, Björn Zethelius, Lars Berglund, Kai M. Eggers, Lars Lind, Bertil Lindahl, Kai C. Wollert & Agneta Siegbahn. (2013) GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men. PLoS ONE 8:12, pages e78797.
Crossref
Crossref
Klaus Unsicker, Björn Spittau & Kerstin Krieglstein. (2013) The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1. Cytokine & Growth Factor Reviews 24:4, pages 373-384.
Crossref
Crossref
Tibor Kempf, Anja Guba-Quint, Jarl Torgerson, Maria Chiara Magnone, Carolina Haefliger, Maria Bobadilla & Kai C Wollert. (2012) Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. European Journal of Endocrinology 167:5, pages 671-678.
Crossref
Crossref